This site is intended for health professionals only

Home
>
Editor’s pick

Editor’s pick

Arthritis drug approved by NICE

Arthritis drug approved by NICE

Afinitor more than doubles time without tumor growth in advanced pancreatic NET patients

Afinitor more than doubles time without tumor growth in advanced pancreatic NET patients

Test predicts breast cancer relapse

Test predicts breast cancer relapse

Novartis provides progress-update to achieving 77% majority ownership of Alcon

Novartis provides progress-update to achieving 77% majority ownership of Alcon

Tory MP launches attack on Nice

Tory MP launches attack on Nice

Drug hope for Parkinson’s patients

Drug hope for Parkinson’s patients

AstraZeneca wins Crestor protection

AstraZeneca wins Crestor protection

New data for Vimpat (lacosamide)

New data for Vimpat (lacosamide)

Warning given over Avandia effects

Warning given over Avandia effects

Shire named Company of the Year at Mediscience Awards

Shire named Company of the Year at Mediscience Awards

Phase III studies demonstrate significantly superior progression free survival with continuous revlimid therapy in diagnosed multiple myeloma

Phase III studies demonstrate significantly superior progression free survival with continuous revlimid therapy in diagnosed multiple myeloma

Study gives Alzheimer’s drug hope

Study gives Alzheimer’s drug hope

« Previous 1 … 56 57 58 59 60 … 302 Next »

Be in the know

Subscribe to Hospital Pharmacy Europe newsletter and magazine

Subscribe

x